Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.

MLA

Russell, Jake, et al. “Myocyte Membrane and Microdomain Modifications in Diabetes: Determinants of Ischemic Tolerance and Cardioprotection.” Cardiovascular Diabetology, vol. 16, no. 1, Dec. 2017, p. 155. EBSCOhost, https://doi.org/10.1186/s12933-017-0638-z.

APA

Russell, J., Du Toit, E. F., Peart, J. N., Patel, H. H., & Headrick, J. P. (2017). Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection. Cardiovascular Diabetology, 16(1), 155. https://doi.org/10.1186/s12933-017-0638-z

Chicago

Russell, Jake, Eugene F Du Toit, Jason N Peart, Hemal H Patel, and John P Headrick. 2017. “Myocyte Membrane and Microdomain Modifications in Diabetes: Determinants of Ischemic Tolerance and Cardioprotection.” Cardiovascular Diabetology 16 (1): 155. doi:10.1186/s12933-017-0638-z.